1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Development of cell assays for exploration of novel immunotherapeutic drugs for cancer treatment
- Master (Two yrs)
-
Mark
Establishment of Precision-Cut Tumor Slices for Pre-Clinical Evaluation of Existing and Novel Therapeutics
- Master (Two yrs)
- 2024
-
Mark
Towards Establishment of an Ex Vivo Bladder Tumor Model using Precision Cut Tumor Slices (PCTS) for Evaluation of Existing and Novel Treatments
- Master (Two yrs)
- 2023
-
Mark
Towards Development of Antibodies Targeting Myeloid and Regulatory T Cells in Bladder Tumours
- Master (Two yrs)
-
Mark
Immune cell landscapes in endometriosis and endometriosis-associated ovarian cancer
- Master (Two yrs)
-
Mark
The Effects of Chemotherapy on B Cells and T Cells in Blood and Tumor Tissue in Patients with Pancreatic Cancer – from Diagnosis to Terminal Disease
- Master (Two yrs)
-
Mark
Characterization of SLC40A1 in Acute Myeloid Leukemia by CRISPRi Gene Editing
- Master (Two yrs)
-
Mark
Sex differences in Health and Disease
- Master (Two yrs)
-
Mark
Investigations of immune population subsets in bladder cancer
- Master (Two yrs)
- 2021
-
Mark
Effect of chemotherapy treatment on the peripheral immune-cellome in patients with pancreatic cancer
- Master (Two yrs)